Zydus Naftifine HCL 2% Cream Gets CDSCO Panel nod to treat superficial fungal infection of skin Dr. Divya Colin1 Nov 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Tells MSN Lab to Produce Raw Data on Icatibant Injection Dr. Divya Colin24 Oct 2022 1:15 PM ISTNew Delhi: In response to drug maker MSN Laboratories' justification for bioavailability (BE) study waiver for Icatibant Injection 30mg/3ml (10mg/ml)...
AstraZeneca Gets CDSCO panel nod to Import, Market Anti-Diabetic Dapagliflozin for Additional Indication Dr. Divya Colin23 Oct 2022 11:30 AM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
SII gets CDSCO panel nod to study Pneumococcal Polysaccharide Conjugate Vaccine,Adsorbed,10-Valent Dr. Divya Colin21 Oct 2022 6:00 PM ISTNew Delhi: Serum Institute of India has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Dr. Reddy's gets CDSCO panel conditional nod to manufacture, market Nimesulide Granules Dr. Divya Colin20 Oct 2022 6:00 PM ISTNew Delhi: Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject...
GSK gets CDSCO Panel nod to market anticancer Niraparib Tablet Susmita Roy12 Oct 2022 6:00 PM ISTNew Delhi: Granting the proposal of a local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Biological E gets CDSCO Panel nod to manufacture, market FDC Chlorpheniramine Maleate,Noscapine Oral Liquids Dr. Divya Colin9 Oct 2022 3:23 PM ISTNew Delhi: Pharmaceutical major, Biological E has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard...
IQVIA Gets CDSCO Panel Nod To Study AVT06 biosimilar candidate to Eylea Dr. Divya Colin9 Oct 2022 1:40 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
Novo-Nordisk gets CDSCO Panel nod to study Human Growth Hormone Analogue Somapacitan Dr. Divya Colin8 Oct 2022 4:36 PM ISTNew Delhi: In line with the pharmaceutical major Novo-Nordisk's proposed protocol amendment on the study of human growth hormone Somapacitan, the...
Submit CT Protocol, Toxicity Report: CDSCO panel Tells Glenmark on respiratory drug combination Dr. Divya Colin7 Oct 2022 6:00 PM ISTNew Delhi: Directing to conduct Phase III clinical trail and inhalation toxicity study of respiratory fixed dose combination drug Glycopyrronium...
JnJ gets CDSCO Panel nod to study antipsychotic drug Paliperidone Palmitate Dr. Divya Colin29 Sept 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard...
CDSCO panel opines Paraxel to study either CKD or heart failure in phase IIb trial of AZD9977,Dapagliflozin FDC Susmita Roy25 Sept 2022 1:28 PM ISTNew Delhi: In line with Paraxel's clinical trial protocol to study efficacy and safety of AZD9977 in combination with dapagliflozin in patients with...
